Yitong Fu

1.2k total citations
31 papers, 987 citations indexed

About

Yitong Fu is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yitong Fu has authored 31 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yitong Fu's work include Nicotinic Acetylcholine Receptors Study (15 papers), Receptor Mechanisms and Signaling (10 papers) and Medical Imaging Techniques and Applications (7 papers). Yitong Fu is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (15 papers), Receptor Mechanisms and Signaling (10 papers) and Medical Imaging Techniques and Applications (7 papers). Yitong Fu collaborates with scholars based in United States, United Kingdom and China. Yitong Fu's co-authors include Burt M. Sharp, Shannon G. Matta, Victoria G. Brower, James D. Valentine, J. Michael McIntosh, Hao Chen, Jianhong Luo, Steven L. Parker, Jon Lindstrom and Wenqing Gao and has published in prestigious journals such as Journal of Neuroscience, Blood and PLoS ONE.

In The Last Decade

Yitong Fu

30 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yitong Fu United States 16 693 446 158 157 154 31 987
Marc R. Azar United States 13 401 0.6× 438 1.0× 193 1.2× 111 0.7× 55 0.4× 24 771
Lipa Čičin‐Šain Croatia 19 259 0.4× 362 0.8× 141 0.9× 66 0.4× 58 0.4× 58 838
Pierre Broqua France 14 291 0.4× 454 1.0× 104 0.7× 133 0.8× 133 0.9× 26 1.0k
Susan Slade United States 17 474 0.7× 382 0.9× 144 0.9× 46 0.3× 50 0.3× 33 790
Karlie A. Intlekofer United States 10 219 0.3× 152 0.3× 173 1.1× 77 0.5× 66 0.4× 10 711
Veronica Fagerholm Finland 13 224 0.3× 186 0.4× 118 0.7× 58 0.4× 42 0.3× 16 665
Sarah Lane United States 12 416 0.6× 679 1.5× 109 0.7× 42 0.3× 48 0.3× 17 998
Marc Muschler Germany 16 435 0.6× 132 0.3× 97 0.6× 48 0.3× 49 0.3× 37 810
D. Garver United States 18 226 0.3× 282 0.6× 90 0.6× 59 0.4× 42 0.3× 35 929
Yavuz Ayhan Türkiye 10 397 0.6× 270 0.6× 45 0.3× 44 0.3× 117 0.8× 32 815

Countries citing papers authored by Yitong Fu

Since Specialization
Citations

This map shows the geographic impact of Yitong Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yitong Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yitong Fu more than expected).

Fields of papers citing papers by Yitong Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yitong Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yitong Fu. The network helps show where Yitong Fu may publish in the future.

Co-authorship network of co-authors of Yitong Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Yitong Fu. A scholar is included among the top collaborators of Yitong Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yitong Fu. Yitong Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaotong, Lei Zhong, Yitong Fu, et al.. (2025). Oxalic acid induced synthesis of renewable Ce-MnFe2O4 nanocatalysts with hybrid crystallinity for enhanced ozone decomposition. Environmental Research. 283. 122111–122111. 1 indexed citations
2.
Fu, Yitong, et al.. (2024). Spinel (Mn, Fe)3O4 Nanocatalyst for the Catalytic Ozone Decomposition under Humid Conditions. ACS Applied Nano Materials. 7(7). 7111–7121. 10 indexed citations
3.
Liu, Xinqi, et al.. (2024). Plasma-catalytic synergistic oxidation of NO in the non-thermal plasma system: Insight into the active sites effect. Journal of environmental chemical engineering. 12(5). 113292–113292. 2 indexed citations
4.
Gregor, Jens, et al.. (2022). Data-driven head motion correction for PET using time-of-flight and positron emission particle tracking techniques. PLoS ONE. 17(8). e0272768–e0272768. 3 indexed citations
5.
Osborne, Dustin, et al.. (2021). The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing Assumptions. Frontiers in Medicine. 8. 684157–684157. 10 indexed citations
7.
Wall, Jonathan S., R. Eric Heidel, Alan Stuckey, et al.. (2020). Detection of Systemic AL Amyloidosis and Differentiation of AL from Attr Using 124I-p5+14 PET Imaging. Blood. 136(Supplement 1). 17–18. 2 indexed citations
8.
Osborne, Dustin, et al.. (2018). Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT. Nuclear Medicine Communications. 39(3). 222–227. 5 indexed citations
9.
Osborne, Dustin, et al.. (2017). 90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT. Clinical Nuclear Medicine. 42(5). 373–374. 3 indexed citations
10.
Zeng, Rong, et al.. (2012). Fibrolipomatous hamartoma of the inferior calcaneal nerve (Baxter nerve). Skeletal Radiology. 41(10). 1323–1326. 5 indexed citations
11.
Wall, Jonathan S., Stephen J. Kennel, Alan Stuckey, et al.. (2010). Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood. 116(13). 2241–2244. 71 indexed citations
12.
Chen, Hao, Yitong Fu, & Burt M. Sharp. (2007). Chronic Nicotine Self-Administration Augments Hypothalamic–Pituitary–Adrenal Responses to Mild Acute Stress. Neuropsychopharmacology. 33(4). 721–730. 48 indexed citations
13.
Sharp, Burt M., et al.. (2004). Effects of Galantamine, a Nicotinic Allosteric Potentiating Ligand, on Nicotine-Induced Catecholamine Release in Hippocampus and Nucleus Accumbens of Rats. Journal of Pharmacology and Experimental Therapeutics. 309(3). 1116–1123. 23 indexed citations
14.
Fu, Yitong, et al.. (2004). Gestational Nicotine Exposure Attenuates Nicotine-Stimulated Dopamine Release in the Nucleus Accumbens Shell of Adolescent Lewis Rats. Journal of Pharmacology and Experimental Therapeutics. 308(2). 521–528. 55 indexed citations
15.
Parker, Steven L., Yitong Fu, Jianhong Luo, et al.. (2004). Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the α6 Subunit. Molecular Pharmacology. 65(3). 611–622. 87 indexed citations
16.
Brower, Victoria G., Yitong Fu, Shannon G. Matta, & Burt M. Sharp. (2002). Rat strain differences in nicotine self-administration using an unlimited access paradigm. Brain Research. 930(1-2). 12–20. 73 indexed citations
17.
Fu, Yitong, Shannon G. Matta, J. Michael McIntosh, & Burt M. Sharp. (1999). Inhibition of nicotine-induced hippocampal norepinephrine release in rats by alpha-conotoxins MII and AuIB microinjected into the locus coeruleus. Neuroscience Letters. 266(2). 113–116. 26 indexed citations
18.
Matta, Shannon G., Yitong Fu, James D. Valentine, & Burt M. Sharp. (1998). Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology. 23(2). 103–113. 118 indexed citations
19.
Fu, Yitong, Shannon G. Matta, James D. Valentine, & Burt M. Sharp. (1998). Desensitization and resensitization of norepinephrine release in the rat hippocampus with repeated nicotine administration. Neuroscience Letters. 241(2-3). 147–150. 15 indexed citations
20.
Fu, Yitong, et al.. (1998). Nicotine-Induced Norepinephrine Release in the Rat Amygdala and Hippocampus is Mediated through Brainstem Nicotinic Cholinergic Receptors. Journal of Pharmacology and Experimental Therapeutics. 284(3). 1188–1196. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026